Streetbeat News

Stock Prices

TYL

Tyler Technologies (NYSE:TYL) reported Q4 earnings with an EPS of $1.89, beating estimates by 1.61% and showing a revenue increase of $28.71 million from the previous year. This follows a pattern of beating EPS estimates in previous quarters, with a notable share price increase of 9.46% after last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

ADPT

Adaptive Biotechnologies (NASDAQ:ADPT) reported its Q4 earnings with an EPS of $-0.3, matching estimates. Revenue decreased by $9.41 million from the previous year. The company had previously missed EPS estimates last quarter, leading to an 18.18% share price drop the following day. Historical earnings performance shows mixed results over the past quarters.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

UDMY

Udemy (NASDAQ:UDMY) reported Q4 earnings with a significant beat on estimated earnings, posting an EPS of $0.02 against an estimate of $-0.02, marking a 200% beat. Revenue increased by $24.21 million from the same period last year. This follows a pattern of beating EPS estimates in previous quarters, with a notable 38.03% share price increase after last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

FROG

JFrog (NASDAQ:FROG) reported Q4 earnings with a 58.33% beat on estimated EPS, reporting $0.19 versus an estimate of $0.12. Revenue increased by $20.71 million from the same period last year. The company has a history of beating EPS estimates, which in the past has led to a significant increase in share price the following day.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

NUS

Nu Skin Enterprises (NYSE:NUS) reported Q4 earnings with a 32.14% beat on EPS estimates, reporting $0.37 versus the expected $0.28. However, revenue decreased by $33.70 million compared to the same period last year. The company's past earnings performance shows a mixed trend with misses and beats in previous quarters.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

CARA

CRBP

EAST

PMD

TLRY

XXII

YCBD

Cannabis stocks experienced significant movements on February 14, 2024, with notable gainers including Choom Holdings, MedMen Enterprises, and MGC Pharmaceuticals, among others. Psychemedics, Cara Therapeutics, 22nd Century Group, Tilray Brands, and Eastside Distilling were among the NASDAQ and NYSE-listed companies that saw gains. Conversely, Maple Leaf Green World, Item 9 Labs, and 1933 Industries led the losers, with cbdMD and Corbus Pharmaceuticals being the notable AMEX and NASDAQ-listed companies facing declines.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:30 pm

CSCO

Cisco Systems, Inc. (NASDAQ:CSCO) reported Q2 earnings of 87 cents per share and sales of $12.8 billion, surpassing analyst expectations. The company announced a workforce reduction of 5%, with estimated pre-tax charges of $800 million. Cisco's Q3 revenue forecast is below analyst expectations, as is the full-year 2024 revenue and earnings forecast. Shares dropped 4.91% after-hours.

Portfolio Pulse from Erica Kollmann

February 14, 2024 | 9:30 pm

SSSS

Trading for SSSS was halted but has now resumed as of 4:30 PM ET, following an update on quotation resumption times.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:30 pm

NUS

Nu Skin Enterprises (NUS) reported Q4 2023 adjusted EPS of $0.37, surpassing the $0.28 estimate, with sales of $488.64M also beating the $476.39M estimate. However, this represents a 6.45% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:29 pm

BRK/A

SIRI

Berkshire Hathaway has increased its stake in Sirius XM Holdings by purchasing an additional 30.559 million shares, bringing its total holdings to 40,243,058 shares.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:29 pm